These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8247433)
21. [Observation on two kinds of recombinant hepatitis B vaccines used in populations with different immunity]. Zhang H; Ma JX; Gong XH; Liu LR; Wu K; Luo FJ; Zhao W; Zeng ZL; Bai YH; Sun LL; Xu W Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):690-3. PubMed ID: 17172109 [TBL] [Abstract][Full Text] [Related]
22. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437 [TBL] [Abstract][Full Text] [Related]
23. Clinical trial of hepatitis B vaccine in a simplified immunization programme. Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032 [TBL] [Abstract][Full Text] [Related]
24. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Lu CY; Chiang BL; Chi WK; Chang MH; Ni YH; Hsu HM; Twu SJ; Su IJ; Huang LM; Lee CY Hepatology; 2004 Dec; 40(6):1415-20. PubMed ID: 15565627 [TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children. Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363 [TBL] [Abstract][Full Text] [Related]
26. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing]. Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384 [TBL] [Abstract][Full Text] [Related]
27. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine]. Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P Sante; 1996; 6(1):11-5. PubMed ID: 8612008 [TBL] [Abstract][Full Text] [Related]
28. Control of hepatitis B: evaluation of two different vaccinal schedules in newborns from HBsAg negative mothers. Belloni C; Orsolini P; Martinetti M; Chirico G; Cerbo RM; Comolli G; Maccarini U; Barlassina C; Togni C; Polatti F New Microbiol; 1993 Jul; 16(3):237-44. PubMed ID: 8366819 [TBL] [Abstract][Full Text] [Related]
29. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067 [TBL] [Abstract][Full Text] [Related]
30. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Huang LM; Chiang BL; Lee CY; Lee PI; Chi WK; Chang MH Hepatology; 1999 Mar; 29(3):954-9. PubMed ID: 10051503 [TBL] [Abstract][Full Text] [Related]
31. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers. Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014 [TBL] [Abstract][Full Text] [Related]
32. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan. Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831 [TBL] [Abstract][Full Text] [Related]
33. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine]. Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590 [TBL] [Abstract][Full Text] [Related]
34. [Long-term efficacy of hepatitis B vaccine in newborn and revaccination study]. Cheng H; Guo Z; Zhang Y Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):76-9. PubMed ID: 7923336 [TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine. Milne A; Heydon JL; Hindle RC; Pearce NE N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277 [TBL] [Abstract][Full Text] [Related]
38. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637 [TBL] [Abstract][Full Text] [Related]
39. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499 [TBL] [Abstract][Full Text] [Related]
40. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]